Skovronsky Daniel
- SEC CIK
- 0001741474
No open-market purchases or sales filed in the past year.
Current role at each company
- MYGN Myriad Genetics IncDirectoras of Jun 23, 2026
- ILMN Illumina, Inc.Directoras of Jun 23, 2026
- LLY Eli Lilly & CoEVP, CS&PO & Pres. LRLas of Feb 11, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Skovronsky Daniel as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
LLY Eli Lilly & Co
EVP, CS&PO & Pres. LRL2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2025 (view filing) | Aug 12 | Same day | Skovronsky DanielEVP, CSO & Pres. LRL & LLY Imm | PPurchase | +1.00K | $634.41 | +$634.4K | +0.7%137.7K after | |
| Feb 12, 2025 (view filing) | Feb 10 | 2 days | Skovronsky DanielEVP, CSO & Pres. LRL & LLY Imm | SSale | −5.00K | $863.21 | −$4.32M | −4.1%117.9K after | 3 lots |